Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA

Slow responders to tuberculosis (TB) treatment in Virginia have prolonged treatment duration and consume more programmatic resources. Diabetes is an independent risk factor for slow response and low serum anti-TB drug concentrations. Thus, a statewide initiative of early therapeutic drug monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Heysell, Scott K., Moore, Jane L., Staley, Debbie, Dodge, Denise, Houpt, Eric R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855970/
https://www.ncbi.nlm.nih.gov/pubmed/24349775
http://dx.doi.org/10.1155/2013/129723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855970/
https://www.ncbi.nlm.nih.gov/pubmed/24349775
http://dx.doi.org/10.1155/2013/129723

Ejemplares similares